Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.

Glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD) is an enzyme that specifically cleaves GPI anchors. Previous human studies suggested the relationship of GPI-PLD to insulin resistance, type 1 and type 2 diabetes, and nonalcoholic fatty liver disease (NAFLD). However, the biological roles of GPI-PLD have not been elucidated. Here, we hypothesized that GPI-PLD impacted on lipid and glucose metabolism, especially in the liver. GPI-PLD mRNA was most highly expressed in the liver, and the hepatic mRNA level and circulating concentration of GPI-PLD were significantly augmented in diabetic mice. To investigate in vivo functions of GPI-PLD, we generated GPI-PLD knockout (GP-KO) mice. Mice lacking GPI-PLD exhibited the amelioration of glucose intolerance and hepatic steatosis under high-fat and high-sucrose diet. Furthermore, diacylglycerol (DAG) content was significantly decreased, and PKCε activity was suppressed in the livers of GP-KO mice. In vitro knockdown and overexpression experiments of GPI-PLD using rat primary hepatocytes showed the GPI-PLD-dependent regulation of intracellular DAG content. Finally, serum GPI-PLD levels were strongly and independently associated with serum alanine transaminase (R = 0.37, P = 0.0006) and triglyceride (R = 0.34, P = 0.001) levels in male subjects with metabolic syndrome. In conclusion, upregulation of hepatic GPI-PLD in diabetic conditions leads to DAG accumulation in the liver by shedding GPI anchors intracellularly, which may play a causal role in impaired hepatic insulin signaling and the progression of NAFLD.

[1]  S. Davies,et al.  Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease , 2017, Hepatology.

[2]  F. Kronenberg,et al.  MASP1, THBS1, GPLD1 and ApoA-IV are novel biomarkers associated with prediabetes: the KORA F4 study , 2016, Diabetologia.

[3]  T. Kinoshita,et al.  Biosynthesis of GPI-anchored proteins: special emphasis on GPI lipid remodeling , 2016, Journal of Lipid Research.

[4]  H. Yki-Järvinen.  Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. , 2014, The lancet. Diabetes & endocrinology.

[5]  Dorothy D. Sears,et al.  Reduced Dietary Omega-6 to Omega-3 Fatty Acid Ratio and 12/15-Lipoxygenase Deficiency Are Protective against Chronic High Fat Diet-Induced Steatohepatitis , 2014, PloS one.

[6]  G. Shulman,et al.  Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes , 2014, Hepatology.

[7]  A. Diehl,et al.  NAFLD, NASH and liver cancer , 2013, Nature Reviews Gastroenterology &Hepatology.

[8]  T. Funahashi,et al.  A Novel Role for Adipose Ephrin-B1 in Inflammatory Response , 2013, PloS one.

[9]  C. Byrne,et al.  Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. , 2013, Annual review of nutrition.

[10]  T. Funahashi,et al.  Low serum eicosapentaenoic acid / arachidonic acid ratio in male subjects with visceral obesity , 2013, Nutrition & Metabolism.

[11]  S. Klein,et al.  Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. , 2012, Gastroenterology.

[12]  G. Shulman,et al.  Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. , 2012, Cell metabolism.

[13]  Xianlin Han,et al.  Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease , 2011, Proceedings of the National Academy of Sciences.

[14]  M. G. Low,et al.  Glycosylphosphatidylinositol-specific phospholipase D improves glucose tolerance. , 2010, Metabolism: clinical and experimental.

[15]  G. Shulman,et al.  The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. , 2009, Cell metabolism.

[16]  A. Simopoulos,et al.  The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases , 2008, Experimental biology and medicine.

[17]  G. Schmitz,et al.  The opposing effects of n-3 and n-6 fatty acids. , 2008, Progress in lipid research.

[18]  G. Shulman,et al.  Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease , 2007 .

[19]  K. Reue,et al.  Three Mammalian Lipins Act as Phosphatidate Phosphatases with Distinct Tissue Expression Patterns* , 2006, Journal of Biological Chemistry.

[20]  N. Chalasani,et al.  Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study. , 2006, The Journal of clinical endocrinology and metabolism.

[21]  G. Carman,et al.  The Saccharomyces cerevisiae Lipin Homolog Is a Mg2+-dependent Phosphatidate Phosphatase Enzyme*♦ , 2006, Journal of Biological Chemistry.

[22]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[23]  C. Ahn,et al.  Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. , 2004, Archives of internal medicine.

[24]  D. Befroy,et al.  Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease* , 2004, Journal of Biological Chemistry.

[25]  N. Fineberg,et al.  Insulin resistance is associated with increased serum levels of glycosylphosphatidylinositol-specific phospholipase D. , 2004, Metabolism: clinical and experimental.

[26]  A. Häkkinen,et al.  Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. , 2002, The Journal of clinical endocrinology and metabolism.

[27]  S. Hurel,et al.  Insulin reduces serum glycosylphosphatidylinositol phospholipase D levels in human type I diabetic patients and streptozotocin diabetic rats. , 2002, Molecular genetics and metabolism.

[28]  L. Olson,et al.  Glucose and insulin regulate glycosylphosphatidylinositol-specific phospholipase D expression in islet beta cells. , 2001, Metabolism: clinical and experimental.

[29]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[30]  I. Shimomura,et al.  Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Tsujioka,et al.  Intracellular cleavage of glycosylphosphatidylinositol by phospholipase D induces activation of protein kinase Calpha. , 1999, The Biochemical journal.

[32]  L. Olson,et al.  Mouse glycosylphosphatidylinositol-specific phospholipase D (Gpld1) characterization , 1998, Mammalian Genome.

[33]  D. Jones,et al.  Glycosyl-phosphatidylinositol-phospholipase type D: a possible candidate for the generation of second messengers. , 1997, Biochemical and biophysical research communications.

[34]  N. Altszuler,et al.  Release of GPI‐anchored membrane proteins by a cell‐associated GPI‐specific phospholipase D. , 1994, The EMBO journal.

[35]  A. Zurbriggen,et al.  Distribution of glycosylphosphatidylinositol-specific phospholipase D mRNA in bovine tissue sections , 1993, Cell and Tissue Research.

[36]  M. G. Low,et al.  Factors affecting the ability of glycosylphosphatidylinositol-specific phospholipase D to degrade the membrane anchors of cell surface proteins. , 1991, The Biochemical journal.

[37]  M. G. Low,et al.  A phospholipase D specific for the phosphatidylinositol anchor of cell-surface proteins is abundant in plasma. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[38]  V. Nussenzweig,et al.  A glycan-phosphatidylinositol-specific phospholipase D in human serum. , 1987, Science.

[39]  W. R. Bishop,et al.  Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. , 1986, The Journal of biological chemistry.

[40]  J. M. Bremner,et al.  Use of p-nitrophenyl phosphate for assay of soil phosphatase activity , 1969 .

[41]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[42]  A. Henriksson,et al.  Plasma glycosylphosphatidylinositol phospholipase D (GPI-PLD) and abdominal aortic aneurysm. , 2012, International journal of clinical and experimental medicine.

[43]  G. Shulman,et al.  Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. , 2007, The Journal of clinical investigation.